Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
AstraZeneca
Chubb
Farmers Insurance
Mallinckrodt
McKinsey
Covington
Fuji
Queensland Health

Generated: February 20, 2018

DrugPatentWatch Database Preview

METHOXSALEN Drug Profile

« Back to Dashboard

When do Methoxsalen patents expire, and when can generic versions of Methoxsalen launch?

Methoxsalen is a drug marketed by Actavis Inc, Idt Australia Ltd, and Strides Pharma. and is included in three NDAs.

The generic ingredient in METHOXSALEN is methoxsalen. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.
Drug patent expirations by year for METHOXSALEN
Pharmacology for METHOXSALEN
Ingredient-typePsoralens
Drug ClassPhotoactivated Radical Generator
Psoralen
Mechanism of ActionPhotoabsorption
Physiological EffectPhotosensitizing Activity
Medical Subject Heading (MeSH) Categories for METHOXSALEN

US Patents and Regulatory Information for METHOXSALEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Inc METHOXSALEN methoxsalen CAPSULE;ORAL 202603-001 Jun 9, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Idt Australia Ltd METHOXSALEN methoxsalen CAPSULE;ORAL 087781-001 Jun 8, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Strides Pharma METHOXSALEN methoxsalen CAPSULE;ORAL 202687-001 Jun 5, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Queensland Health
QuintilesIMS
Dow
Deloitte
Federal Trade Commission
Baxter
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot